These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. Isolated limb perfusion for melanoma patients--a review of its indications and the role of tumour necrosis factor-alpha. Grünhagen DJ; de Wilt JH; van Geel AN; Eggermont AM Eur J Surg Oncol; 2006 May; 32(4):371-80. PubMed ID: 16520016 [TBL] [Abstract][Full Text] [Related]
44. [Locoregional use of TNF (tumor necrosis factor) in the treatment of malignant melanoma]. Lejeune F Pathol Biol (Paris); 1990 Oct; 38(8):883-4. PubMed ID: 1703292 [No Abstract] [Full Text] [Related]
45. Early destruction of tumor vasculature in tumor necrosis factor-alpha-based isolated limb perfusion is responsible for tumor response. Hoving S; Seynhaeve AL; van Tiel ST; aan de Wiel-Ambagtsheer G; de Bruijn EA; Eggermont AM; ten Hagen TL Anticancer Drugs; 2006 Sep; 17(8):949-59. PubMed ID: 16940805 [TBL] [Abstract][Full Text] [Related]
46. Blood leakage and melphalan leakage from the perfusion circuit during regional hyperthermic perfusion for malignant melanoma. Hafström L; Hugander A; Jönsson PE; Westling H; Ehrsson H Cancer Treat Rep; 1984 Jun; 68(6):867-72. PubMed ID: 6733699 [TBL] [Abstract][Full Text] [Related]
47. Systemic or regional chemotherapy: does it matter and should surgeons be involved? Stephens FO J R Coll Surg Edinb; 1998 Apr; 43(2):80-1. PubMed ID: 9621525 [TBL] [Abstract][Full Text] [Related]
48. Repeat isolated limb perfusion with melphalan for recurrent melanoma of the limbs. Klop WM; Vrouenraets BC; van Geel BN; Eggermont AM; Klaase JM; Nieweg OE; Kroon BB J Am Coll Surg; 1996 Jun; 182(6):467-72. PubMed ID: 8646345 [TBL] [Abstract][Full Text] [Related]
51. The application of hyperthermia in regional chemotherapy. Di Filippo F; Anzà M; Rossi CR; Cavaliere F; Botti C; Lise M; Garinei R; Giannarelli D; Vasselli S; Zupi G; Cavaliere R Semin Surg Oncol; 1998; 14(3):215-23. PubMed ID: 9548604 [TBL] [Abstract][Full Text] [Related]
52. Is there a role for isolated limb perfusion with tumor necrosis factor in patients with melanoma? De Wilt JH; Thompson JF Ann Surg Oncol; 2004 Feb; 11(2):119-21. PubMed ID: 14761911 [No Abstract] [Full Text] [Related]
53. [Combined treatment of malignant tumors of the extremities. Regional perfusion chemotherapy]. Kolessov VI; Levin AO Minerva Med; 1970 Sep; 61(71):3673-5. PubMed ID: 4989391 [No Abstract] [Full Text] [Related]
54. Isolated limb perfusion for localized melanoma of the extremity. A matched comparison of wide local excision with isolated limb perfusion and wide local excision alone. Edwards MJ; Soong SJ; Boddie AW; Balch CM; McBride CM Arch Surg; 1990 Mar; 125(3):317-21. PubMed ID: 2306179 [TBL] [Abstract][Full Text] [Related]
55. Complete and lasting healing of bone melanoma metastasis after hyperthermic limb perfusion. Pigozzo J; De Rossi C; Rossi CR; Nitti D; Sileni VC Melanoma Res; 2009 Jun; 19(3):193-4. PubMed ID: 19436179 [No Abstract] [Full Text] [Related]
56. High dose recombinant tumour necrosis factor (rTNF alpha) administered by isolation perfusion for advanced tumours of the limbs: a model for biochemotherapy of cancer. Lejeune FJ Eur J Cancer; 1995 Jun; 31A(6):1009-16. PubMed ID: 7646901 [No Abstract] [Full Text] [Related]
57. Hyperthermic perfusion in malignant melanoma: 5-year results. Tonak J; Hohenberger W; Weidner F; Göhl H Recent Results Cancer Res; 1983; 86():229-38. PubMed ID: 6648004 [TBL] [Abstract][Full Text] [Related]
58. Hyperthermic isolation limb perfusion for malignant melanoma: a review. Coit DG Cancer Invest; 1992; 10(4):277-84. PubMed ID: 1628227 [No Abstract] [Full Text] [Related]
59. Continuous intraoperative external monitoring of perfusate leak using iodine-131 human serum albumin during isolated perfusion of the liver and limbs. Barker WC; Andrich MP; Alexander HR; Fraker DL Eur J Nucl Med; 1995 Nov; 22(11):1242-8. PubMed ID: 8575471 [TBL] [Abstract][Full Text] [Related]
60. Results of regional hyperthermic perfusion for primary and recurrent melanomas of the extremities. Jönsson PE; Hafström L; Hugander A Recent Results Cancer Res; 1983; 86():277-82. PubMed ID: 6648009 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]